<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016112"><a href="http://purl.obolibrary.org/obo/MONDO_0016112">MONDO:0016112</a></h3>
<p><strong>Label:</strong> inclusion myopathy</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0011603">MONDO:0011603</a> (GNE myopathy), <a href="http://purl.obolibrary.org/obo/MONDO_0010684">MONDO:0010684</a> (X-linked myopathy with excessive autophagy), <a href="http://purl.obolibrary.org/obo/MONDO_0008178">MONDO:0008178</a> (inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_615422">OMIM:615422</a>, <a href="http://www.orpha.net/ORDO/Orphanet_52430">Orphanet:52430</a>, <a href="http://www.orpha.net/ORDO/Orphanet_25980">Orphanet:25980</a>, <a href="http://purl.obolibrary.org/obo/OMIM_617158">OMIM:617158</a>, <a href="http://purl.obolibrary.org/obo/OMIM_310440">OMIM:310440</a>, <a href="http://purl.obolibrary.org/obo/OMIM_167320">OMIM:167320</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615424">OMIM:615424</a>, <a href="http://purl.obolibrary.org/obo/OMIM_605820">OMIM:605820</a>, <a href="http://www.orpha.net/ORDO/Orphanet_602">Orphanet:602</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0011021">HP:0011021</a> (Abnormality of circulating enzyme level) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0010876">HP:0010876</a> (Abnormality of circulating protein level) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003236">HP:0003236</a> (Elevated serum creatine phosphokinase) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0011021">HP:0011021</a> (Abnormality of circulating enzyme level) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0010876">HP:0010876</a> (Abnormality of circulating protein level) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003236">HP:0003236</a> (Elevated serum creatine phosphokinase) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001324">HP:0001324</a> (Muscle weakness) and <a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001324">HP:0001324</a> (Muscle weakness) and <a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0011021">HP:0011021</a> (Abnormality of circulating enzyme level) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001324">HP:0001324</a> (Muscle weakness) and <a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0010876">HP:0010876</a> (Abnormality of circulating protein level) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001324">HP:0001324</a> (Muscle weakness) and <a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003236">HP:0003236</a> (Elevated serum creatine phosphokinase) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001324">HP:0001324</a> (Muscle weakness) and <a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0003198">HP:0003198</a> (Myopathy) and <a href="http://purl.obolibrary.org/obo/HP_0003797">HP:0003797</a> (Limb-girdle muscle atrophy) 66.67%</li>
</ul>
</body>
</html>
